U.S. Physical Therapy (NYSE:USPH) Price Target Raised to $122.00

U.S. Physical Therapy (NYSE:USPH) had its price objective boosted by analysts at Barrington Research from $110.00 to $122.00 in a research report issued on Friday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Barrington Research‘s price target indicates a potential upside of 22.87% from the stock’s previous close.

A number of other equities analysts have also commented on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 26th. JPMorgan Chase & Co. increased their price objective on U.S. Physical Therapy from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, September 11th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $104.25.

U.S. Physical Therapy Trading Up 0.7%

Shares of U.S. Physical Therapy stock traded up $0.69 on Friday, hitting $99.30. The stock had a trading volume of 56,829 shares, compared to its average volume of 205,026. The stock has a 50 day moving average of $85.91 and a 200 day moving average of $77.31. The firm has a market capitalization of $1.48 billion, a P/E ratio of -73.55, a PEG ratio of 2.75 and a beta of 1.16. U.S. Physical Therapy has a twelve month low of $58.19 and a twelve month high of $101.80. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.42 and a current ratio of 1.42.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Thursday, November 5th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.76 by $0.04. U.S. Physical Therapy had a net margin of 3.60% and a return on equity of 10.19%. The firm had revenue of $222.56 million for the quarter, compared to analyst estimates of $214.48 million. During the same period in the previous year, the firm posted $0.66 EPS. The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. Sell-side analysts expect that U.S. Physical Therapy will post 2.87 earnings per share for the current fiscal year.

Institutional Investors Weigh In On U.S. Physical Therapy

Large investors have recently added to or reduced their stakes in the business. BlackRock Inc. bought a new stake in U.S. Physical Therapy in the second quarter worth approximately $155,505,000. Copeland Capital Management LLC boosted its holdings in shares of U.S. Physical Therapy by 11.8% during the 3rd quarter. Copeland Capital Management LLC now owns 940,528 shares of the company’s stock worth $80,632,000 after buying an additional 98,984 shares in the last quarter. Bahl & Gaynor LLC grew its position in shares of U.S. Physical Therapy by 3.2% during the 3rd quarter. Bahl & Gaynor LLC now owns 889,265 shares of the company’s stock worth $76,237,000 after buying an additional 27,691 shares during the period. William Blair Investment Management LLC grew its position in shares of U.S. Physical Therapy by 50.9% during the 3rd quarter. William Blair Investment Management LLC now owns 659,509 shares of the company’s stock worth $56,540,000 after buying an additional 222,513 shares during the period. Finally, Bank of America Corp DE increased its stake in shares of U.S. Physical Therapy by 10.9% in the 1st quarter. Bank of America Corp DE now owns 554,621 shares of the company’s stock valued at $41,574,000 after acquiring an additional 54,656 shares in the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics across the United States. Its clinics provide rehabilitation for musculoskeletal conditions, orthopedic injuries, sports-related injuries and recovery following surgery, along with other therapy services tailored to patients’ needs. Founded in 1990 and headquartered in Houston, Texas, the company also provides industrial injury prevention and related services to employers. Its clinic network serves communities in multiple states, with care delivered through local therapy practices.